clofibric acid has been researched along with Weight Gain in 3 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, R | 1 |
| Murakami, T | 1 |
| Obayashi, M | 1 |
| Nakai, N | 1 |
| Jaskiewicz, J | 1 |
| Fujiwara, Y | 1 |
| Shimomura, Y | 1 |
| Harris, RA | 1 |
| Sleilati, GG | 1 |
| Leff, T | 1 |
| Bonnett, JW | 1 |
| Hegele, RA | 1 |
| Klinger, W | 1 |
| Lupp, A | 1 |
| Karge, E | 1 |
| Oelschläger, H | 1 |
| Rothley, D | 1 |
| Danz, M | 1 |
| Linss, W | 1 |
| Löbel, S | 1 |
| Deufel, T | 1 |
| Müller, M | 1 |
| Klinger, M | 1 |
| Kühnel, W | 1 |
3 other studies available for clofibric acid and Weight Gain
| Article | Year |
|---|---|
Clofibric acid stimulates branched-chain amino acid catabolism by three mechanisms.
Topics: 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); Administration, Oral; Amino Acids, Branched-Chain | 2002 |
Efficacy and safety of pioglitazone in treatment of a patient with an atypical partial lipodystrophy syndrome.
Topics: Adult; Clofibric Acid; Female; Humans; Hypoglycemic Agents; Insulin; Lipodystrophy, Familial Partial | 2007 |
Ciprofibrate--racemate and enantiomers: effects of a four-week treatment on male inbred Fischer rats. A biochemical and morphological study.
Topics: Administration, Oral; Animals; Cholesterol; Clofibric Acid; Cytochrome P-450 Enzyme System; Dose-Res | 1998 |